Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients

NCT01342822 is registered in ClinicalTrials.gov with European Cardiovascular Research Center as lead sponsor.

NCT NCT01342822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01342822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multi-center Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in a Population of Unrestricted Patients
Lead sponsor
European Cardiovascular Research Center
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2010
Completion date
March 31, 2014
Enrollment
2,980 (estimated)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery stenosis, ischemic heart disease